lundi 3 octobre 2016

Onco Actu du 3 octobre 2016

1. Biologie

Nobel Prize goes to Japanese scientist for work on key cellular recycling process [STAT]

Nobel honors discoveries on how cells eat themselves [Science]

Medicine Nobel for research on how cells 'eat themselves' [Nature]

The Nobel Prize in Physiology or Medicine 2016 Yoshinori Ohsumi [Nobel Prize]

2.6 Etiologie - Environnement

Childhood leukaemia probably caused by mystery virus raising hopes for a vaccination [The Telegraph]

Cancer clusters at nuclear sites 'not linked to radiation' [BBC News]

3.3 Prévention - Vaccins

Physician Recommendations for HPV Vaccine Can Affect Parents’ Choices [AACR]

4.9 Dép., diag. & prono. - Sein

Miniature implanted ‘scaffold’ could detect breast cancer spread [Cancer Research UK]

5.10 Traitements - Essais

Prostate cancer treatment needs to get more personalized [STAT]

5.12.1 Immunothérapies - partenariats

Cancer Research UK, MSD, Verastem collaborate on immunotherapy [Center Watch]

5.2 Pharma

ImmunoGen’s new CEO retrenches, axing 65 staffers and looking to thin pipeline [EndPoints]

5.2.1 Pharma - Partenariats

The trans-Atlantic quest to find a winning combination of cancer drugs [Cancer Research UK]

After patient fatality, Hanmi loses Boehringer, gains Roche in $800M-plus cancer-partner shuffle [FiercePharma]

Following lethal tox report, Boehringer scraps plans for high-speed development, kills $730M Hanmi deal [EndPoints]

5.2.2 Pharma - Fusions & Acquisitions

Scoop: Celgene targets a cure for myeloma/lymphoma with $600M EngMab buyout [EndPoints]

5.2.3 Pharma - économie

$95M mega-round in hand, Elaine Sullivan sets out to build a European oncology player [EndPoints]

5.4 Traitements - Economie

Drugmakers Point Finger at Middlemen for Rising Drug Prices [Wall Street Journal]

5.6 ESMO

First phase III data on Roche’s TECENTRIQ (atezolizumab) to feature at the 2016 European Society for Medical Oncology (ESMO) Congress [Roche]

New Edition of ESMO/ASCO Global Curriculum in Medical Oncology – Setting Standards for Modern Training [ESMO]

6. Lutte contre les cancers

TARGET Initiative Fueling Progress Against Childhood Leukemia [NCI]

What's Different About Male Breast Cancer? [Forbes]

6.1 Observation

Breast cancer treatments vary widely in cost and complications [Reuters]

6.11 Patients

We need to talk about side effects [Cancer Rersearch UK]

'Until 20,' A Film About A Young Cancer Patient's End-Of-Life Decisions [Forbes]

6.7.1 Bioinformatique

Making the modern radiologist obsolete? How machine learning may revolutionize medicine [STAT]

6.7.2 Applis

Dial M for Medicine [Genome Mag]

6.9 Controverses

When science- and evidence-based guidelines conflict with patient wishes: What’s a doc to do? [Science-Based Medicine]